Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Aims To appraise the clinical and genetic evidence that low-density lipoproteins (LDLs)
cause atherosclerotic cardiovascular disease (ASCVD). Methods and results We assessed …

Члены Комитета экспертов подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Комитета …

Члены Рабочей группы: Арутюнов ГП, Баранова ЕИ, Барбараш ОЛ, Бойцов СА,
Вавилова ТВ, Виллевальде СВ, Галявич АС, Глезер МГ, Гринева ЕН, Гринштейн ЮИ …

Importance Lipid management typically focuses on levels of low-density lipoprotein
cholesterol (LDL-C) and, to a lesser extent, triglycerides (TG). However, animal models and …

Eight years have passed since the publication of the only guideline on cardiac rehabilitation
(CR) in Japan,“Guidelines for rehabilitation in patients with cardiovascular disease (JCS …

Background In cholesterol guidelines, low-density lipoprotein (LDL) cholesterol remains the
primary target while apolipoprotein B (apoB) and non–high-density lipoprotein (non-HDL) …

Background Inability to tolerate statins because of muscle symptoms contributes to
uncontrolled cholesterol levels and insufficient cardiovascular risk reduction. Bempedoic …

Importance The conventional model of atherosclerosis presumes that the mass of
cholesterol within very low-density lipoprotein particles, low-density lipoprotein particles …

2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …